Sydney, March 29: Despite being severely low on immunity levels, blood cancer patients generate strong responses against SARS-CoV-2 after vaccination, on par with that of healthy individuals, according to a research.
A study published in Cell Reports Medicine describes that COVID-19 vaccines induce strong T cell response in blood cancer patients, irrespective of antibody response and B cell numbers.
Despite being severely low on immunity levels, blood cancer patients generate strong responses against SARS-CoV-2 after vaccination, on par with that of healthy individuals, according to a research.Researchers from the University of Melbourne .
Researchers found that, despite being heavily immunocompromised, haematology patients generate strong cellular immune responses against SARS-CoV-2 after vaccination, on par with that of healthy individuals.